Media Summary: "This data doesn't prove anything, it just suggests that The "Mad Money" host discussed how investors responded to the latest developments in the race for a Covid-19 You can't just dump the pandemic plays and swap into the reopening

Jim Cramer Breaks Down How Moderna Vaccine Progress Sparked Stocks To Rally - Detailed Analysis & Overview

"This data doesn't prove anything, it just suggests that The "Mad Money" host discussed how investors responded to the latest developments in the race for a Covid-19 You can't just dump the pandemic plays and swap into the reopening CNBC's "Squawk on the Street" team discusses "I expect the reopening plays to keep climbing, while the Covid-winners get hammered for the rest of the week," the "Mad Money" ... President Joe Biden on Tuesday said the U.S. will have a large enough supply of coronavirus

CNBC's "Squawk on the Street" crew discuss the latest in the fight against Covid-19 by developing therapeutics and a The U.S. can beat the coronavirus before a Covid-19 A key Food and Drug Administration advisory panel will review and vote on Johnson & Johnson's single-shot Covid-19 "The Pfizer news represents a new chapter for the market," the "Mad Money" host said. Subscribe to CNBC PRO for access to ... "We figured we'd have maybe the virus contained in early fall, but we botched the reopening and now states are being forced to ...

Photo Gallery

Jim Cramer breaks down how Moderna vaccine progress sparked stocks to rally
Jim Cramer breaks down Moderna's vaccine progress impact on the market
Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine
Jim Cramer breaks down the 'cross-current' of vaccine news, rising virus cases
Jim Cramer on Covid-19 vaccine potential: Next is going to be AstraZeneca
Jim Cramer: Pfizer vaccine news is a 'new chapter for the market'
Jim Cramer: Coronavirus stocks came back with a 'vengeance'
Jim Cramer on vaccine progress boosting sentiment
Jim Cramer on race to develop a vaccine, and reopening U.S. economy from Covid-19 lockdowns
Jim Cramer: The recovery plays have a new reason to rally
Jim Cramer: I wasn't hopeful about coronavirus vaccine but Fauci's optimism could change my mind
Jim Cramer: People ought to calm down on new vaccine results
Sponsored
Sponsored
View Detailed Profile
Jim Cramer breaks down how Moderna vaccine progress sparked stocks to rally

Jim Cramer breaks down how Moderna vaccine progress sparked stocks to rally

"This data doesn't prove anything, it just suggests that

Jim Cramer breaks down Moderna's vaccine progress impact on the market

Jim Cramer breaks down Moderna's vaccine progress impact on the market

The "Mad Money" host discussed how investors responded to the latest developments in the race for a Covid-19

Sponsored
Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine

Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine

"Mad Money" host

Jim Cramer breaks down the 'cross-current' of vaccine news, rising virus cases

Jim Cramer breaks down the 'cross-current' of vaccine news, rising virus cases

You can't just dump the pandemic plays and swap into the reopening

Jim Cramer on Covid-19 vaccine potential: Next is going to be AstraZeneca

Jim Cramer on Covid-19 vaccine potential: Next is going to be AstraZeneca

CNBC's "Squawk on the Street" team discusses

Sponsored
Jim Cramer: Pfizer vaccine news is a 'new chapter for the market'

Jim Cramer: Pfizer vaccine news is a 'new chapter for the market'

"I expect the reopening plays to keep climbing, while the Covid-winners get hammered for the rest of the week," the "Mad Money" ...

Jim Cramer: Coronavirus stocks came back with a 'vengeance'

Jim Cramer: Coronavirus stocks came back with a 'vengeance'

After the coronavirus

Jim Cramer on vaccine progress boosting sentiment

Jim Cramer on vaccine progress boosting sentiment

President Joe Biden on Tuesday said the U.S. will have a large enough supply of coronavirus

Jim Cramer on race to develop a vaccine, and reopening U.S. economy from Covid-19 lockdowns

Jim Cramer on race to develop a vaccine, and reopening U.S. economy from Covid-19 lockdowns

CNBC's "Squawk on the Street" crew discuss the latest in the fight against Covid-19 by developing therapeutics and a

Jim Cramer: The recovery plays have a new reason to rally

Jim Cramer: The recovery plays have a new reason to rally

The U.S. can beat the coronavirus before a Covid-19

Jim Cramer: I wasn't hopeful about coronavirus vaccine but Fauci's optimism could change my mind

Jim Cramer: I wasn't hopeful about coronavirus vaccine but Fauci's optimism could change my mind

CNBC's

Jim Cramer: People ought to calm down on new vaccine results

Jim Cramer: People ought to calm down on new vaccine results

CNBC's

Jim Cramer: I want to see if anyone at Moderna sold stock today or tomorrow

Jim Cramer: I want to see if anyone at Moderna sold stock today or tomorrow

CNBC's

Jim Cramer on how J&J's stock has performed in relation to vaccine news

Jim Cramer on how J&J's stock has performed in relation to vaccine news

A key Food and Drug Administration advisory panel will review and vote on Johnson & Johnson's single-shot Covid-19

Jim Cramer: The U.S. needs a 'clear plan' to distribute vaccines

Jim Cramer: The U.S. needs a 'clear plan' to distribute vaccines

"My bet is that the

Jim Cramer: Fixing the Covid-19 vaccine rollout is crucial for markets, economy

Jim Cramer: Fixing the Covid-19 vaccine rollout is crucial for markets, economy

CNBC's

Jim Cramer expects a 'multiday sell-off in the Covid names'

Jim Cramer expects a 'multiday sell-off in the Covid names'

"The Pfizer news represents a new chapter for the market," the "Mad Money" host said. Subscribe to CNBC PRO for access to ...

Jim Cramer: We desperately need another round of federal stimulus, despite vaccine progress

Jim Cramer: We desperately need another round of federal stimulus, despite vaccine progress

"We figured we'd have maybe the virus contained in early fall, but we botched the reopening and now states are being forced to ...

Jim Cramer: Moderna could have been more transparent about needing funds for vaccine trial

Jim Cramer: Moderna could have been more transparent about needing funds for vaccine trial

CNBC's David Faber, Meg Tirrell and

Jim Cramer on how the market is reacting to the government's vaccine deal with Pfizer

Jim Cramer on how the market is reacting to the government's vaccine deal with Pfizer

CNBC's